Reactome: A Curated Pathway Database

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Roger, Pierre P

Class:IdPerson:8942856
_displayNameRoger, Pierre P
_timestamp2017-08-22 20:43:51
affiliation[Affiliation:8949908] IRIBHM, Free University of Brussels (ULB)
created[InstanceEdit:8942855] Orlic-Milacic, Marija, 2016-10-20
crossReference[DatabaseIdentifier:8949906] ORCID:0000-0002-5812-1783
firstnamePierre P
initialPP
modified[InstanceEdit:8949909] Orlic-Milacic, Marija, 2016-11-30
surnameRoger
urlhttp://iribhm.org/index.php/our-research-group/roger
(author)[LiteratureReference:8942858] Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation
[LiteratureReference:8942863] CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point
[LiteratureReference:8942879] Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase
[LiteratureReference:8949552] Regulation of CDK4
[LiteratureReference:8949846] The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis
[LiteratureReference:8949889] Combined inhibition of MEK and mammalian target of rapamycin abolishes phosphorylation of cyclin-dependent kinase 4 in glioblastoma cell lines and prevents their proliferation
[InstanceEdit:8949903] Roger, Pierre P, 2016-11-04
[Change default viewing format]
No pathways have been reviewed or authored by Roger, Pierre P (8942856)